Many states are looking to lower drug prices in 2021, and a recent Supreme Court ruling opens the door to state regulation of pharmacy middlemen and health care rate regulations. State legislatures will continue their crackdown on insulin prices and more states are expected to take advantage of the federal drug importation demonstration. Supreme Court PBM ruling opens the door for state action Last month, The Supreme Court ruled in favor of an Arkansas law that regulates how much...